Antiamnesic potentiality of Argyreia speciosa (Burm.f) Boj. in mice

P. V. Habbu, K. M. Mahadevan, R. A. Shastry, S. R. Chilakwad

Abstract


Several ‘rasayana’ herbs that are enlisted in Indian system of medicine have been in use for the treatment of age-related neurodegenerative
disorders including Alzheimer’s disease (AD). Roots of Argyreia speciosa are used in several Ayurvedic preparations as brain tonic
and nervine tonic. The present work was undertaken to justify the traditional claim of the plant as nootropic and antiamnesic agent
in mice. The ethyl acetate and ethanolic fractions (EtAS) of roots were selected for the study. Exteroceptive behavioural models such
as elevated plus maze and Water maze were used to assess the short-term memory, whereas, scopolamine and natural ageing- induced
amnesia served as interoceptive models. The whole brain acetyl cholinesterase activity was measured to assess the effect of A. speciosa
on the central cholinergic system. Scopolamine (0.4 mg/kg, i.p.) increased the transfer latency significantly (P,0.01) in young mice
on the first and second day as compared to control indicating the impairment of memory. Pretreatment with EAAS (100 and 200 mg/
kg, p.o.) significantly (P,0.01) attenuated scopolamine and ageing-induced amnesia. Escape latency time was recorded in the water
maze model as an index of acquisition, and trials were conducted for 4 days. The mean time spent in target quadrant (TSTQ) during
retrieval trial on fifth day was taken as the index of retrieval (memory). EAAS (100 and 200 mg/kg, p.o.) administered before the
training trial (from day 1 to day 4), significantly (P,0.01) attenuated scopolamine and ageing-induced decrease in TSTQ during the
retrieval test on the fifth day. EAAS (100 and 200 mg/kg, p.o.) significantly produced reduction in whole brain acetyl cholinesterase
(AChE) activity of both young and aged mice thus exhibiting anti-AChE activity in whole brain homogenate compared to Piracetam,
scopolamine and control groups of mice. The results indicate that A. speciosa has significant nootropic and antiamnesic activity,
justifying its traditional use in Ayurveda.
Key words: Antiamnesic, Argyreia speciosa, ayurveda, nootropic, rasayana

Full Text:

PDF

References


Esch T, Stefano GB, Fricchione GL, Benson H. The role of stress in

neurodegenerative diseases and mental disorders. Neuroendocr

Lett 2002;23:199-208.

Jodar L, Takahashi M, Kaneto H. Effect of footshock-psychological

and forged swimming stress on the learning and memory

process: Involvement of opiodergic pathways. Jpn J Pharmacol

;67:143- 7.

Meguro K, Ueda M, Yamaguchi T, Seikita Y, Yamazaki H, Oikawa Y,

et al. Disturbance in daily sleep/wake patterns in patients with

cognitive impairment and decreased daily activity. J Am Geriatr

Soc 1990;38:1176-82.

Meguro K, Ueda M, Kobayashi I. Sleep disturbance in elderly

patients with cognitive impairment, decreased daily activity and

periventricular white matter lesions. Sleep 1995;18:109-14.

Meguro K, Yamaguchi S, Yamazaki H, Itoh M, Yamaguchi T,

Matsui H, et al. Cortical glucose metabolism in psychiatric wandering

patients with vascular dementia. Psychiatr Res 1996;67:71-80.

Katzman R, Terry R, DeTeresa R, Brown T, Brown T, Davies P,

et al. Clinical, pathological and neurochemical changes in

dementia: Asubgroup with preserved mental status and numerous

neocortical plaques. Ann Neurol 1988;23:138-44.

Bhattacharya SK, Upadhyay SN, Jaiswal AK. Effect of Piracetam on

electroshock induced amnesia and decrease in brain acetylcholine

in rats. Indian J Exp Biol 1993;31:822-4.

Warrier PK, Nambiar VP, Ramankutty C. Indian medicinal plants:

A compendium of 500 species. New Delhi: Orient Longman

Publishers: 1994. p. 191-4.

Sharma PC, Yelne, MB, Dennis TJ. In: Database on medicinal plants

used in Ayurveda. New Delhi: Central Council for Research in

Ayurveda and Siddha; 2004. p. 550.

Gokhale AB, Damre AS, Kulkarni KR, Saraf MN. Preliminary

evaluation of anti-inflammatory and anti-arthritic activity of

S.lappa, A. speciosa and A. aspera. Phytomedicine 2002;9:433-7.

Gokhale AB, Damre AS, Saraf MN. Investigations in to the

Immunomodulatory activity of Argyreia speciosa. J Ethnopharmacol

;84:109-14.

Habbu PV, Shastry RA, Mahadevan KM, Joshi H, Das SK,

Hepatoprotective and antioxidant effects of Argyreia speciosa in

rats. Afr J Trad Compl Altern Med 2008;5:158-64.

Petra M, Britta T, Macki K, Eckart E. Flavanoid sulphates from

Convolvulaceae. Phytochemistry 1999;50:267-71.

Srivastava A, Shukla Y, Aryl esters and a Coumarin from Argyreia

speciosa. Indian J Chem. Br 1998;37:192-4.

Shukla YN, Srivastava A, Sunilkumar, Sushilkumar. Phytotoxic

and antimicrobial constituents of Argyreia speciosa and Oenothera

biennis. J Ethanopharmacol 1999;67:241-5.

Reed IJ, Munch H. Toxicity studies in experimental Animals. Am

J Hygiene 1992;27:493-8.

Itoh J, Nabeshima T, Kameyama T. Utility of an elevated

plus maze for the evaluation of nootropics, scopolamine and

electroconvulsive shock. Psychopharmacology 1990;101:27-33.

Parle M, Singh N. Animal models for testing memory. Asia Pac

J Pharmacol 2004;16:101-20.

Parle M, Singh N. Reversal of memory deficits by Atorvastatin

and Simvastatin in rats. Yakugaku Zasshi 2007;127:1125-37.

Ellman GL, Courtney KD, Valentino A, Featherstone RM. A new

and rapid colorimetric determination of acetyl cholinesterase

activity. Biochem Pharmacol 1961;7:88-95.

Hashimotto M, Rockenstein E, Crews L, Masliah E. Role of protein

aggregation in mitochondrial dysfunction and neurodegeneration

in Alzheimer’s and Parkinson’s diseases. Neuromolecular Med

;4:21-36.

Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L. Soluble

amyloid beta peptide concentration as a predictor of synaptic

change in Alzheimer’s disease. Am J Pathol 1999;155:853-62.

Pillot T, Drouet B, Queille S, Labeur C, Vandekerchkhove J,

Rosseneu M. The nonfibrillar amyloid beta-peptide induces

apoptotic neuronal cell death: Involvement of its C-terminal

fusogenic domain. J Neurochem 1999;73:1626-34.

Sponne I, Fifre A, Drouet B, Klein C, Koziel V, Pincon-Raymond M.

Apoptotic neuronal cell death induced by the non-fibrillar

amyloid-beta peptide proceeds through an early reactive oxygen

species-dependent cytoskeleton perturbation. J Biol Chem

;278:3437-45.

Kriem B, Sponne I, Fifre A, Malaplate-Armand C, Lozac’hPillot K,

Koziel V. Cytosolic phospholipase A2 mediates neuronal apoptosis

induced by soluble oligomers of the amyloid-ß peptide. FASEB J

;19:85-7.

Fifre A, Spin I, Kozeil V, Kriem B, Yen Potin FT, Bihain BE.

Microtubule-associated protein MAP1A, MAP1B, and MAP2

proteolysis during soluble amyloid beta-peptide-induced neuronal

apoptosis. Synergistic involvement of calpain and caspase-3. J Biol

Chem 2006;281:229-40.

Drouet B, Pin-con Raymond M, Chambaz J, Pillot T. Molecular

basis of Alzheimer’s disease. Cell Mol Life Sci 2000 57:705-15.

Kirkitaze MD, Bitan G, Teplow DB, Paradigm shifts in Alzheimer’s

disease and other neurodegenerative disorders: The emerging role

of oligomeric assemblies. J Neurosci Res 2002;69:567-77.

Singh RH, Udupa KN. Clinical and experimental studies on

rasayana drugs and rasayana therapy, Central council for research

in Ayurveda and Siddha, Ministry of Health and family welfare,

New Delhi: 1993.

Beigon A, Greenberger V, Segal M. Quantitative histochemistry of

brain acetyl cholinesterase and learning in the aged rat. Neurobiol

Aging 1986;7:215-7.

Perry EK. Cholinergic component of cognitive impairment in

dementia. In: Dementia. Burns A, Levy R, Chapman and Hall;

p. 29.

Agarwal SL, Bhargava V. Effect of drugs on brain acetylcholine

level in rats. Indian J Med Res 1964;52:1179-82.

Sudha S, Madepalli K, Lakshmana PN. Chronic phenytoin induced

impairment of learning and memory with associated changes

in brain acetyl cholinesterase activity and monoamine levels.

Pharmacol Biochem Behav 2001;52:119-24.




DOI: http://dx.doi.org/10.22377/ijgp.v4i2.125

Refbacks

  • There are currently no refbacks.